Gene · 9547
Papers2,447
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,447
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advanced-stage cutaneous T-cell lymphomas show distinct immune profiles in erythroderma vs. tumor lesions. | J Dermatol Sci | 2026 | 42810908 | PubTator, text mining | PubMed |
| Somatic Mutation Profile in Normal Tissue Adjacent to Tumor in Colorectal Carcinoma Patients: Functional Effect on Gene Expression and Potential Implications for Precision Medicine. | Cancers (Basel) | 2026 | 42795000 | PubTator, text mining | PubMed |
| Age-related changes of FCGR3A+ natural killer cells and their association with elderly atopic dermatitis. | EBioMedicine | 2026 | 42771994 | PubTator, text mining | PubMed |
| Single-cell and spatial multi-omics reveal a recurrent multicellular niche at the tumor-stroma interface in multidrug resistance. | Cell Rep Med | 2026 | 42748914 | PubTator, text mining | PubMed |
| Discovery and validation of a multi-protein panel for predicting non-fatal major adverse cardiovascular events in diabetic kidney disease. | Front Endocrinol (Lausanne) | 2026 | 42723880 | PubTator, text mining | PubMed |
| Hepatic expression of IL-8, IL-10, and CXCL-14 in drug-induced liver injury: correlation with histopathology and prognostic value. | Front Pharmacol | 2026 | 42656426 | PubTator, text mining | PubMed |
| Hepatitis Viruses Infection Up-Regulating Fibrosis Signals in Hepatocellular Carcinoma. | Biomedicines | 2026 | 42652100 | PubTator, text mining | PubMed |
| CXCL14 is a novel biomarker for mast cell infiltration in the melanoma tumor microenvironment. | J Dermatol Sci | 2026 | 42618356 | PubTator, text mining | PubMed |
| Identification of CXCL13 as an agonist and CXCL11 as an inverse agonist for the viral G protein-coupled receptor ORF74. | Biochem Pharmacol | 2026 | 42556478 | PubTator, text mining | PubMed |
| NF-κB/OCT-1 Mediated Upregulation of CXCL14 Chemokine Mobilizes Mucosal Effector Memory CD44+CD62L-CD4+ and CD8+ TEM Cells, and NK Cells Associated with Protection Against Genital Herpes. | Pathog Immun | 2026 | 42524223 | PubTator, text mining | PubMed |
| Integrated single-cell and spatial transcriptomics reveals a multicellular program contributing to immunotherapy resistance and adverse clinical outcomes in clear cell renal cell carcinoma. | NPJ Precis Oncol | 2026 | 42481778 | PubTator, text mining | PubMed |
| FOXP2+ Chief Cells and CXCL14+ Fibroblasts Drive Fibrotic Remodeling in Carotid Body Tumors. | Int J Mol Sci | 2026 | 42450023 | PubTator, text mining | PubMed |
| The oral-gut-joint axis in osteoarthritis: a multiomics case-control study. | Front Cell Infect Microbiol | 2026 | 42440607 | PubTator, text mining | PubMed |
| scRNA-seq and genomics analyses reveal key mechanisms of inverted papilloma-associated sinonasal squamous cell carcinoma malignant transformation. | bioRxiv | 2026 | 42415849 | PubTator, text mining | PubMed |
| TBX6 promotes proliferation, invasion, and migration in colorectal cancer: Integrated transcriptomic and protein interaction network analysis. | Gene | 2026 | 42401341 | PubTator, text mining | PubMed |
| Pilot spatial transcriptomics of dental pulpitis suggests immune-fibroblast profiling linked to reversibility. | J Transl Med | 2026 | 42399991 | PubTator, text mining | PubMed |
| MiR-139 modulates CD8+ T cells exhaustion by targeting CD28 in breast cancer. | iScience | 2026 | 42389592 | PubTator, text mining | PubMed |
Sinomenine protects against oxidized low-density lipoprotein-induced human umbilical vein endothelial cell injury through regulating the myocyte enhancer factor 2 A/C-X-C motif chemokine ligand 14 pathway. | J Bioenerg Biomembr | 2026 | 42384327 | PubTator, text mining | PubMed |
| MAPK-driven glioma progression and reprogramming of the tumor-associated immune response. | Neuro Oncol | 2026 | 42377256 | PubTator, text mining | PubMed |
| A Novel CAF-Related Signature for Precise Prediction of Clinical Outcomes and Immunotherapy Response for Breast Cancer Patients: Based on Multiomics Analyses and Experimental Validation. | Mediators Inflamm | 2026 | 42359574 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9547/papers